ACM
DXCM icon

American Capital Management’s DexCom DXCM Stock Holding History

American Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Buy
251,475
+2,701
+1% +$188K 0.85% 37
2025
Q4 		$16.5M Sell
248,774
-109,016
-30% -$7.05M 0.73% 37
2025
Q3 		$24.1M Buy
357,790
+2,217
+0.6% +$175K 0.96% 29
2025
Q2 		$31M Sell
355,573
-45,220
-11% -$3.54M 1.29% 28
2025
Q1 		$27.4M Buy
400,793
+94,789
+31% +$7.74M 1.11% 34
2024
Q4 		$23.8M Sell
306,004
-47,795
-14% -$3.54M 0.89% 38
2024
Q3 		$23.7M Sell
353,799
-3,007
-0.8% -$247K 0.78% 37
2024
Q2 		$40.5M Buy
356,806
+1,260
+0.4% +$159K 1.35% 27
2024
Q1 		$49.3M Sell
355,546
-7,842
-2% -$986K 1.58% 23
2023
Q4 		$45.1M Buy
363,388
+41,539
+13% +$4.24M 1.54% 22
2023
Q3 		$30M Buy
321,849
+31,238
+11% +$3.52M 1.16% 29
2023
Q2 		$37.3M Sell
290,611
-2,213
-0.8% -$268K 1.3% 25
2023
Q1 		$34M Buy
292,824
+10,207
+4% +$1.14M 1.2% 26
2022
Q4 		$32M Buy
282,617
+1,943
+0.7% +$213K 1.25% 25
2022
Q3 		$22.6M Sell
280,674
-894
-0.3% -$75.7K 0.89% 34
2022
Q2 		$21M Buy
281,568
+2,332
+0.8% +$213K 0.79% 34
2022
Q1 		$35.7M Buy
279,236
+7,376
+3% +$807K 1.05% 30
2021
Q4 		$36.5M Sell
271,860
-944
-0.3% -$136K 0.94% 33
2021
Q3 		$37.3M Sell
272,804
-2,816
-1% -$355K 1% 33
2021
Q2 		$29.4M Buy
275,620
+39,812
+17% +$3.82M 0.82% 34
2021
Q1 		$21.2M Buy
235,808
+61,800
+36% +$5.8M 0.64% 39
2020
Q4 		$16.1M Buy
174,008
+55,904
+47% +$4.99M 0.48% 42
2020
Q3 		$12.2M Buy
118,104
+1,728
+1% +$181K 0.45% 41
2020
Q2 		$11.8M Buy
116,376
+1,744
+2% +$156K 0.43% 44
2020
Q1 		$7.72M Buy
+114,632
New +$7.13M 0.38% 45

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Capital Management's DXCM Position: Q1 2026 in Review

American Capital Management increased its DexCom (DXCM) stake by 1.1% in Q1 2026, buying an estimated $188K and bringing the position to 251,475 shares worth $15.8M. The position accounts for 0.85% of the portfolio, ranked #37.

American Capital Management first reported a position in DXCM in Q1 2020 and has held it in 25 quarters since. The position peaked at $49.3M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • American Capital Management held 251,475 shares of DexCom worth $15.8M as of Q1 2026.
  • American Capital Management bought 2,701 DexCom shares in Q1 2026, an estimated $188K.
  • DexCom made up 0.85% of American Capital Management's portfolio in Q1 2026, its #37 holding.
  • American Capital Management first reported a position in DexCom in Q1 2020 and has held it in 25 quarters since.
  • American Capital Management's DexCom position peaked at $49.3M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on American Capital Management's 13F filing for Q1 2026, filed 15 May 2026.